Lactate dehydrogenase-to albumin ratio (LAR) is associated with early-onset cognitive impairment after acute ischemic stroke

Background Post-stroke cognitive impairment (PSCI) is the most prevalent complication of acute ischemic stroke(AIS) in individuals. The lactate dehydrogenase-to albumin ratio (LAR) is a novel indicator that measures systemic inflammation and nutritional status. The purpose of this research was to investigate the connection between the LAR and PSCI. Methods Following inclusion criteria, this study recruited 701 AIS patients who were segmented into the PSCI (n = 441) and non-PSCI (n = 260) groups according to the Mini-Mental State Examination (MMSE) within 2 weeks after stroke. The lactate dehydrogenase and albumin levels were measured within 24 h after hospitalization. A binary logistic regression was constructed to examine the association between LAR and PSCI with the LAR divided into tertiles. Results The PSCI group showed a higher level of LAR in comparison to the non-PSCI group (p < 0.001). Compared with T1 (≦4.93), patients in the highest quartile of LAR (≧5.93) had a greater risk of PSCI after controlling for confounding factors, as demonstrated by logistic regression (odds ratio (OR) = 2.003, 95 % confidence interval (CI) = 1.305–3.074, P = 0.001). Conclusion Higher LAR is independently related to the development of cognitive impairment in the early phase after stroke, which may help physicians in the early identification of patients with PSCI.